BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27908729)

  • 1. Structural and biochemical characterization of FabK from Thermotoga maritima.
    Ha BH; Shin SC; Moon JH; Keum G; Kim CW; Kim EE
    Biochem Biophys Res Commun; 2017 Jan; 482(4):968-974. PubMed ID: 27908729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae reveals the binding mode of an inhibitor.
    Saito J; Yamada M; Watanabe T; Iida M; Kitagawa H; Takahata S; Ozawa T; Takeuchi Y; Ohsawa F
    Protein Sci; 2008 Apr; 17(4):691-9. PubMed ID: 18305197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK).
    Hevener KE; Santarsiero BD; Lee H; Jones JA; Boci T; Johnson ME; Mehboob S
    Acta Crystallogr F Struct Biol Commun; 2018 Feb; 74(Pt 2):105-112. PubMed ID: 29400320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).
    Marrakchi H; Dewolf WE; Quinn C; West J; Polizzi BJ; So CY; Holmes DJ; Reed SL; Heath RJ; Payne DJ; Rock CO; Wallis NG
    Biochem J; 2003 Mar; 370(Pt 3):1055-62. PubMed ID: 12487627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and structural characterization of the trans-enoyl-CoA reductase from Treponema denticola.
    Bond-Watts BB; Weeks AM; Chang MC
    Biochemistry; 2012 Aug; 51(34):6827-37. PubMed ID: 22906002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization and preliminary X-ray analysis of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae.
    Saito J; Yamada M; Watanabe T; Kitagawa H; Takeuchi Y
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jun; 62(Pt 6):576-8. PubMed ID: 16754986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and Structural Insights Concerning Triclosan Resistance in a Novel YX
    Khan R; Zeb A; Choi K; Lee G; Lee KW; Lee SW
    Sci Rep; 2019 Oct; 9(1):15401. PubMed ID: 31659200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, purification and characterization of enoyl-ACP reductase II, FabK, from Porphyromonas gingivalis.
    Hevener KE; Mehboob S; Boci T; Truong K; Santarsiero BD; Johnson ME
    Protein Expr Purif; 2012 Sep; 85(1):100-8. PubMed ID: 22820244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of Enoyl-ACP reductases I (FabI) and III (FabL) from B. subtilis.
    Kim KH; Ha BH; Kim SJ; Hong SK; Hwang KY; Kim EE
    J Mol Biol; 2011 Feb; 406(3):403-15. PubMed ID: 21185310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of a hypothetical protein, TM841 of Thermotoga maritima, reveals its function as a fatty acid-binding protein.
    Schulze-Gahmen U; Pelaschier J; Yokota H; Kim R; Kim SH
    Proteins; 2003 Mar; 50(4):526-30. PubMed ID: 12577257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The X-ray structure of Escherichia coli enoyl reductase with bound NAD+ at 2.1 A resolution.
    Baldock C; Rafferty JB; Stuitje AR; Slabas AR; Rice DW
    J Mol Biol; 1998 Dec; 284(5):1529-46. PubMed ID: 9878369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylimidazole derivatives of 4-pyridone as dual inhibitors of bacterial enoyl-acyl carrier protein reductases FabI and FabK.
    Kitagawa H; Ozawa T; Takahata S; Iida M; Saito J; Yamada M
    J Med Chem; 2007 Sep; 50(19):4710-20. PubMed ID: 17713898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of TM1457 from Thermotoga maritima.
    Shin DH; Lou Y; Jancarik J; Yokota H; Kim R; Kim SH
    J Struct Biol; 2005 Nov; 152(2):113-7. PubMed ID: 16242963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsaturated fatty acid synthesis in Enterococcus faecalis requires a specific enoyl-ACP reductase.
    Dong H; Cronan JE
    Mol Microbiol; 2022 Nov; 118(5):541-551. PubMed ID: 36100979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficient translation renders the Enterococcus faecalis fabK enoyl-acyl carrier protein reductase phenotypically cryptic.
    Bi H; Zhu L; Wang H; Cronan JE
    J Bacteriol; 2014 Jan; 196(1):170-9. PubMed ID: 24163335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.
    Lu H; Tonge PJ
    Biochemistry; 2010 Feb; 49(6):1281-9. PubMed ID: 20055482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and Structural Basis of Triclosan Resistance in a Novel Enoyl-Acyl Carrier Protein Reductase.
    Khan R; Zeb A; Roy N; Thapa Magar R; Kim HJ; Lee KW; Lee SW
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization and preliminary X-ray crystallographic analysis of enoyl-ACP reductase III (FabL) from Bacillus subtilis.
    Kim KH; Park JK; Ha BH; Moon JH; Kim EE
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Mar; 63(Pt 3):246-8. PubMed ID: 17329825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile Infection.
    Marreddy RKR; Wu X; Sapkota M; Prior AM; Jones JA; Sun D; Hevener KE; Hurdle JG
    ACS Infect Dis; 2019 Feb; 5(2):208-217. PubMed ID: 30501172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Characterization of an ACP from
    Lee Y; Jang A; Jeong MC; Park N; Park J; Lee WC; Cheong C; Kim Y
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.